Skip to main content
Fig. 5 | Head & Face Medicine

Fig. 5

From: Investigating resistin like beta (RETNLB) as a tumor promoter for oral squamous cell carcinoma

Fig. 5

The effect of RETNLB knockdown on the TLR2/4/ERK signaling pathway-related markers. (a) Gene set enrichment analysis showed the enrichment of the TLR signature in the high RETNLB expression group according to the RNA-Seq dataset from the The Cancer Genome Atlas. (b, c, d) The protein levels of TLR2, TLR4, p-ERK, and ERK in CAL27 (b, c) and TCA-83 (b, d) cells were determined by western blot after transfected with si-NC and si-RETNLB. (b) Images of representative protein bands. (c, d) Protein expression histogram of markers in CAL27 (c) and TCA-83 (d) cells. Data are presented as means ± standard deviation. Columns, means. Bars, standard deviations. **p < 0.01 vs. si-NC group

Back to article page